BDX
Becton Dickinson and Company
NYSE: BDX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$145.31
-2.82% today
Updated 2026-04-29
Market cap
$41.34B
P/E ratio
23.74
P/S ratio
1.89x
EPS (TTM)
$6.12
Dividend yield
2.79%
52W range
$125 – $186
Volume
2.7M
Becton Dickinson and Company (BDX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+0.3%
Last 4 quarters
Revenue YoY growth
+1.6%
Most recent quarter
EPS YoY growth
-15.2%
Most recent quarter
When is the next earnings report?
Reporting date
March 31, 2026
Consensus EPS estimate
$3.33
Fiscal period ending
2026-03-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.3%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+12.2%
2025-08-07
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-03 | $2.91 | -10.2% | $201.91 | $207.87 | +3.0% |
| 2025-11-06 | $3.96 | +1.0% | $176.39 | $177.84 | +0.8% |
| 2025-08-07 | $3.68 | +8.2% | $172.41 | $193.50 | +12.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $3.33 | — | — | — | — |
| 2025-12-31 | $3.24 | $2.91 | -10.2% | $5.25B | +1.6% |
| 2025-09-30 | $3.92 | $3.96 | +1.0% | $5.89B | +8.3% |
| 2025-06-30 | $3.40 | $3.68 | +8.2% | $5.51B | +10.4% |
| 2025-03-31 | $3.28 | $3.35 | +2.1% | $5.27B | +4.5% |
| 2024-12-31 | $2.99 | $3.43 | +14.7% | $5.17B | +9.8% |
| 2024-09-30 | $3.77 | $3.81 | +1.1% | $5.44B | +6.9% |
| 2024-06-30 | $3.31 | $3.50 | +5.7% | $4.99B | — |
| 2024-03-31 | $2.97 | $3.17 | +6.7% | $5.04B | — |
| 2023-12-31 | $2.40 | $2.68 | +11.7% | $4.71B | — |
| 2023-09-30 | $3.43 | $3.42 | -0.3% | $5.09B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $12.57 | $19.5B | +-10.8% | 12 | high |
| 2027 (E) | $13.63 | $19.9B | +2.2% | 12 | high |
| 2028 (E) | $15.20 | $21.0B | +5.6% | 12 | medium |
| 2029 (E) | $16.95 | $22.6B | +7.4% | 12 | medium |
| 2030 (E) | $18.85 | $24.3B | +7.6% | 12 | medium |
Frequently asked questions
When does Becton Dickinson and Company report next earnings?
Becton Dickinson and Company (BDX) is scheduled to report earnings on March 31, 2026. The consensus EPS estimate is $3.33.
Has Becton Dickinson and Company beaten earnings estimates?
Becton Dickinson and Company has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +0.3% over the last 4 quarters.
How does BDX stock react to earnings?
BDX stock has moved an average of +5.3% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Becton Dickinson and Company's revenue growth rate?
Becton Dickinson and Company reported year-over-year revenue growth of +1.6% in its most recent quarter, with EPS growing -15.2% year-over-year.
What is the expected EPS for BDX in 2026?
Analysts expect Becton Dickinson and Company to report EPS of $12.57 for fiscal year 2026, on revenue of $19.5B, based on estimates from 12 analysts.